Market Trends of Middle East And Africa Diabetes Care Devices Industry
Continuous glucose monitoring segment is expected to witness highest growth rate over the forecast period
The continuous glucose monitoring segment is expected to register a CAGR of 16.8% over the forecast period.
Continuous glucose monitoring devices are automated glucose monitoring systems that consist of a small device that can be worn on the body and held on by an adhesive patch. The sensor part of the device has a cannula that is inserted into the top layer of skin and uses samples of interstitial fluid to check glucose levels. Sensors are connected to a transmitter that can send data wirelessly to a dedicated mobile receiving device or smartphone.
The use of CGMs by people with diabetes and their caregivers and communities is beneficial for managing their blood glucose and insulin levels and maintaining their health outcomes. CGM makes it significantly easier to manage blood glucose levels by decreasing interruptions, allowing for better sleep, and improving the mental health of patients or caregivers by reducing the overall mental load of managing diabetes.
Continuous glucose monitoring sensors use glucose oxidase to detect blood sugar levels. Glucose oxidase converts glucose to hydrogen peroxidase, which reacts with the platinum inside the sensor, producing an electrical signal to be communicated to the transmitter. Continuous glucose monitoring has become a popular alternative to the portable finger-prick glucometers available on the market for the convenience of diabetic patients. Sensors are the most important part of continuous glucose monitoring devices.
A large variety of promising glucose-sensing technologies, from traditional electrochemical-based glucose sensors to novel optical and other electrical glucose sensors, have been developed, which has had a positive impact on market growth. Technological advancements to improve the accuracy of the sensors are expected to drive segment growth during the forecast period.
Saudi Arabia is expected to witness highest CAGR in the Middle East and Africa Diabetes Care Devices Market over the forecast period
Saudi Arabia is expected to register the highest CAGR of about 5.08% in the Middle East and Africa Diabetes Care Devices Market over the forecast period.
More than one in ten people in Saudi Arabia were living with diabetes, and the prevalence of the disease was expected to almost double by 2045, according to the report of the International Diabetes Federation. The report mentioned that 4.27 million people in Saudi Arabia have diabetes. The rise in the number of people with type-2 diabetes is driven by a complex interplay of socio-economic, demographic, environmental, and genetic factors. Key contributors include urbanization, an aging population, decreasing levels of physical activity, and increased levels of overweight and obesity.
The Saudi government announced in July 2022 that Saudi Arabia saw growing demand for quality healthcare services spurred by changes, including an increasing and aging population and a growing prevalence of lifestyle diseases such as diabetes and obesity. The government and private sector are both involved in working on healthcare entities, certifications, and regulations. The government is taking steps to have 100 percent of Saudi citizens covered by insurance and is working towards ensuring affordability, access, and quality digital healthcare and primary care with cost-effectiveness.
Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in the Middle East and Africa region.
